Teleporting to San Diego: A Journey Through Clinical Developments in Gout
38
Teleporting to San Diego: A Journey Through Clinical Developments in Gout
description
Teleporting to San Diego: A Journey Through Clinical Developments in Gout . ACR 2013: Abstract 1183. Background. Methods. Prevalence of Gout Is Rising. Characteristics Associated With SUA Above Target. Study Conclusion/Discussion. ACR 2013: Abstract 2003. Background. Methods . Findings. - PowerPoint PPT Presentation
Transcript of Teleporting to San Diego: A Journey Through Clinical Developments in Gout
![Page 1: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/1.jpg)
Teleporting to San Diego: A Journey Through Clinical Developments in Gout
![Page 2: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/2.jpg)
![Page 3: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/3.jpg)
ACR 2013: Abstract 1183
![Page 4: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/4.jpg)
Background
![Page 5: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/5.jpg)
Methods
![Page 6: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/6.jpg)
Prevalence of Gout Is Rising
![Page 7: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/7.jpg)
Characteristics Associated With SUA Above Target
![Page 8: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/8.jpg)
Study Conclusion/Discussion
![Page 9: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/9.jpg)
ACR 2013: Abstract 2003
![Page 10: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/10.jpg)
Background
![Page 11: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/11.jpg)
Methods
![Page 12: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/12.jpg)
Findings
![Page 13: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/13.jpg)
Proportion of Patients Reaching Goal in 6 Months
![Page 14: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/14.jpg)
Conclusions/Discussion
![Page 15: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/15.jpg)
ACR 2013: Abstract 1185
![Page 16: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/16.jpg)
Background
![Page 17: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/17.jpg)
Methods
![Page 18: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/18.jpg)
Patient Characteristics, SUA ≤ 6 mg/dL Based on Flares
![Page 19: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/19.jpg)
Clinical Context
![Page 20: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/20.jpg)
Conclusions/Discussion
![Page 21: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/21.jpg)
ACR 2013: Abstract 1723
![Page 22: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/22.jpg)
Background
![Page 23: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/23.jpg)
Methods
![Page 24: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/24.jpg)
ACR 2013: Abstract 1191
![Page 25: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/25.jpg)
Background
![Page 26: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/26.jpg)
Methods
![Page 27: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/27.jpg)
Results
![Page 28: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/28.jpg)
ACR 2013: Abstract 1195
![Page 29: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/29.jpg)
Background
![Page 30: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/30.jpg)
Methods
![Page 31: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/31.jpg)
Findings
![Page 32: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/32.jpg)
Findings (cont)
![Page 33: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/33.jpg)
Abbreviations
![Page 34: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/34.jpg)
Abbreviations (cont)
![Page 35: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/35.jpg)
References
![Page 36: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/36.jpg)
References
![Page 37: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/37.jpg)
![Page 38: Teleporting to San Diego: A Journey Through Clinical Developments in Gout](https://reader035.fdocuments.in/reader035/viewer/2022062520/56816589550346895dd845f5/html5/thumbnails/38.jpg)